Vinyoflex Ltd — Important, 13-11-2025: Company Update

Hester Biosciences posted a strong Q2 FY26, with consolidated net profit jumping 71% year-on-year to 14.33 crore. Revenue hit 70.97 crore, while EBITDA climbed to 23.60 crore (33% margin). For the first half of FY26, net profit surged 99% to 31.63 crore on 155.07 crore revenue, driven by operational discipline. The company anticipates market stabilization and institutional demand recovery ahead, despite current subdued order flows in some regions. A robust performance signaling resilience.